Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Adaptive activation of thyroid hormone and energy expenditure.
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Racial disparities in kidney transplant waitlist appearance in Chicago: Is it race or place?
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2024 01; 22(1):144-153.e2.
View in:
PubMed
subject areas
Administration, Intravenous
Crohn Disease
Humans
Induction Chemotherapy
Remission Induction
Treatment Outcome
Ustekinumab
authors with profiles
Stephen B. Hanauer